Investigating skin metabolites as a new way to diagnose Parkinson


Study ID: 30993
Short Title: Skin metabolites in Parkinson's disease
Organisation: Southern Health NHS Foundation Trust
Location: Southern Health NHS Foundation Trust
Condition: Parkinson's disease
Main Specialty: Neurological disorders
Expected End Date: 02/04/2018
Postcode: SO30 3JB
Contact Name: SHFT Research
Contact Email: research@southernhealth.nhs.uk
Active: Yes

Inclusion Criteria

For participants with Parkinson's disease


1. The participant has Parkinson's disease.


2. The participant is between the ages of 18 and 90.


3. The participant is able to understand the study and consent into the study.


For control participants


1. The participant is between the ages of 18 and 90.


2. The participant is able to understand the study and consent into the study.


For seborrhoea participants


1. The participant has seborrhoea or seborrhoeic dermatitis.


2. The participant does not have Parkinson's disease.


3. The participant is between the ages of 18 and 90.


4. The participant is able to understand the study and consent into the study.


For participants in the PREDICT-PD study


1. The participant is in the PREDICT-PD study.

Exclusion Criteria

Parkinson's disease participants As long as the participant is within the age range of the study and willing and able to provide informed consent then they will not be excluded from the study.


Control Participants


1. The participant does not have any significant Neurological or medical condition which may affect the results of the study.

Study summary:


In our initial pilot research we have demonstrated that there is a difference in the metabolites in the skin between
subjects who have Parkinson's disease (PD) and those who don't. We hope to be able to develop a simple new test
for PD that will involve rubbing a gauze swab on the skin and measuring the chemicals in the swab. We will use as
chemistry technique called mass spectrometry to analyse all the chemicals. So far we have only studied small
numbers of people. Having received funding from Parkinson's UK we now want to study much larger numbers of
people with and without PD in order to determine whether we can use this method as a very simple test for PD.


« Study Map« List of studies